Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?


UNLABELLED What's known on the subject? and What does the study add? Previous reports, with small numbers of patients, have described the problem of incomplete testosterone suppression (>1.1 or 1.7 nmol/L) with LHRH agonists. Various predisposing factors have been suggested: different drug agents and patient factors such as age, pretreatment testosterone… (More)
DOI: 10.1111/j.1464-410X.2012.11190.x